The prognosis impact of BCR-ABL P-loop mutations: worse or not worse? (Q79656737)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17251899%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

editorial

0 references

title

The prognosis impact of BCR-ABL P-loop mutations: worse or not worse? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17251899%20AND%20SRC:MED&resulttype=core&format=json

Catherine Roche-Lestienne

24 December 2019

author

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17251899%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17251899%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Nicolini FE

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17251899%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Corm S

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17251899%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Lê QH

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17251899%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

publication date

1 February 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17251899%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17251899%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17251899%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17251899%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

page(s)

193-194

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17251899%20AND%20SRC:MED&resulttype=core&format=json

Frequency and clinical significance of BCR-ABL mutations in patients with chronic myeloid leukemia treated with imatinib mesylate

24 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404490

7 January 2021

Mutation status and clinical outcome of 89 imatinib mesylate-resistant chronic myelogenous leukemia patients: a retrospective analysis from the French intergroup of CML (Fi(phi)-LMC GROUP)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404490

7 January 2021

Detection of BCR-ABL mutations in patients with CML treated with imatinib is virtually always accompanied by clinical resistance, and mutations in the ATP phosphate-binding loop (P-loop) are associated with a poor prognosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404490

7 January 2021

ABL mutations in late chronic phase chronic myeloid leukemia patients with up-front cytogenetic resistance to imatinib are associated with a greater likelihood of progression to blast crisis and shorter survival: a study by the GIMEMA Working Party o

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404490

7 January 2021